semaglutide cardiovascular indication Effects on Outcomes in People With Overweight or Obesity (SELECT) rationale and design Cardiovascular outcomes of semaglutide and

If you are a professional or competitive amateur athlete subject to doping control, the safest course of action is to: Check the latest WADA Prohibited List for your sport

At refrigerated temperatures of 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit), stability extends to the full 28-day window

When compared to placebo or reference therapy, vildagliptin had a marginally significant beneficial effect on liver fat and showed a mild reduction in serum ALT levels, whereas sitagliptin did not

Phase 2 data suggests retatrutide may produce greater weight reduction than currently approved agents, but its long-term safety profile has not been fully established, and no head-to-head regulatory-grade trials have been completed